Concert Genetics
Marshall McQuillen has a diverse background in data engineering, machine learning operations, data science, and data analysis. Marshall is currently working as a Senior Data Engineer at Concert Genetics since August 2022. Prior to that, they were a ML Ops Engineer at RevSpring from October 2021 to October 2022. From November 2019 to October 2021, they held a role as a Data Scientist at Medalogix. Marshall also gained experience as a Senior Data Analyst at Markit from October 2018 to July 2019. Before that, they briefly worked as an Associate Data Science Instructor at Galvanize Inc from July 2018 to October 2018. Marshall also has experience outside of the data field, serving as a General Manager at Kayak Chile from January 2016 to April 2016 and as a Website Designer at Redrocks Construction LLC from June 2015 to September 2015.
Marshall McQuillen has a diverse education history. In 2014, they enrolled in Colorado State University and completed their studies in Business Administration and Management, with a focus on general business practices. Marshall continued their pursuit of knowledge in 2018 by attending Galvanize Inc, where they studied Data Science for a brief period. Marshall also holds additional certifications to enhance their skills. In 2017, they obtained a Data Science Specialization certificate from Coursera, which provided him with in-depth knowledge in data science techniques. In the same year, they completed the "Excel to MySQL: Analytic Techniques for Business" course, also from Coursera. To stay up-to-date with advancements in the field, Marshall obtained certification as an AWS Certified Cloud Practitioner from Amazon Web Services (AWS) in 2021.
This person is not in any offices
Concert Genetics
Genetic testing is the lynchpin of precision medicine, but the rapid pace of change in the market makes it enormously complex. Today, there are more than 75,000 unique genetic testing products on the market, and an average of 10 new products are added each day. This growth confounds the processes through which tests are ordered, resulted, billed and reimbursed. Founded in 2010 with a vision to simplify this complexity, Concert Genetics (formerly NextGxDx, Inc.) launched as a healthcare technology company dedicated to streamlining the genetic test selection, ordering, payment and management for clinicians, hospitals, laboratories and health plans. With a leading team of clinicians, researchers, data scientists and software engineers, Concert Genetics launched its proprietary solutions to enable end-to-end genetic testing management, from searching and comparing testing products, to tracking orders and results, to payment integrity and forecasting trends in pricing and utilization. Today, stakeholders across the healthcare system turn to Concert Genetics to better understand and navigate the rapid transformation to precision medicine that is underway.